Covaxin had much lower adverse effects and overall favourable short-term safety profile in adolescents: Study, Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com

These were the findings of a study conducted by researchers at Benaras Hindu University on adolescent (15-18 years) and adult (over 19 years) recipients of Covaxin that claims to be the first real-world safety analysis of Covaxin., These were the findings of a study conducted by researchers at Benaras Hindu University on adolescent (15-18 years) and adult (over 19 years) recipients of Covaxin that claims to be the first real-world safety analysis of Covaxin., , Read More